tiprankstipranks
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
US Market

Lexeo Therapeutics, Inc. (LXEO) Stock Investors

83 Followers
Based on 747,525 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold LXEO
On average, investors allocate 0.00% of their portfolios to LXEO
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,525 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding LXEO

1.7%
Last 7
Days
2.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding LXEO, out of 747,525 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

LXEO Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$16.83
Based on the activity of 14,195 investors who made their portfolios public
The table shows changes in LXEO in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

LXEO Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Bristol-Myers Squibb
3.23%
-0.90%
+1.25%
86.44B
Healthcare
Marathon Digital Holdings
5.78%
-0.18%
+0.20%
6.75B
Financial
Celsius Holdings
4.46%
+0.24%
+2.74%
11.56B
Consumer Defensive
DraftKings
5.81%
-1.48%
-2.00%
32.41B
Consumer Cyclical
Vertiv Holdings
4.52%
-0.68%
+1.83%
31.94B
Industrials
Arista Networks
4.35%
-0.76%
+4.01%
103.59B
Technology
Microstrategy
7.07%
+1.56%
+7.77%
31.55B
Technology
Trade Desk
4.67%
-1.31%
+0.13%
46.96B
Technology
Raytheon Technologies
4.04%
-1.17%
-1.61%
136.69B
Industrials
UiPath
3.29%
-1.66%
-2.81%
6.90B
Technology
Based on the activity of 747,525 active portfolios
Open your Smart Portfolio

LXEO Investor Analysis

LXEO investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
0.0%
of LXEO holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
LXEO investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
25.0%
of LXEO holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
LXEO investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
75.0%
of LXEO holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of LXEO stock investors
See who invests in LXEO according to age group and performance.

FAQ

How many retail Investors hold LXEO?
<0.1% of TipRanks' retail investors hold LXEO in their portfolios.
    What is LXEO Investor Sentiment?
    LXEO’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of LXEO in the last 7 days?
      ▲ 1.7% of TipRanks' retail investors changed their holding of LXEO in the last 7 days.
        What percentage of retail investors changed their holding of LXEO in the last 30 days?
        ▼ 2.0% of TipRanks' retail investors changed their holding of LXEO in the last 30 days.
          What is the average age of retail investors who hold LXEO?
          The average age of LXEO Holders is over 55.
            What other stocks have LXEO investors also bought?
            LXEO Investors also bought BMY, MARA, CELH, DKNG, VRT, ANET, MSTR, TTD, RTX, PATH.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CYTKCytokinetics
              DHRDanaher
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis